Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma Elizabeth M. E. VerdegaalConny HoogstratenSusanne Osanto Original Article 22 August 2006 Pages: 587 - 600
Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors Nectaria N. SotiriadouNikoletta L. KallinterisConstantin N. Baxevanis Original Article 08 September 2006 Pages: 601 - 613
Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells Azizul HaqueArabinda DasSwapan K. Ray Original Article 01 September 2006 Pages: 615 - 625
Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells Thomas PutzReinhold RamonerMartin Thurnher Original Article 01 September 2006 Pages: 627 - 640
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients François GhiringhelliCedric MenardBruno Chauffert Original Article 08 September 2006 Pages: 641 - 648
Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy Brandon StottMladen Korbelik Original Article 01 September 2006 Pages: 649 - 658
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells Jon Amund KyteGunnar KvalheimGustav Gaudernack Original Article 01 September 2006 Pages: 659 - 675
Tumor specific phage particles promote tumor regression in a mouse melanoma model Fredrik ErikssonW. David CulpPavel Pisa Original Article 12 September 2006 Pages: 677 - 687
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles Takafumi MinamiSatoko MatsuedaMamoru Harada Original Article 26 August 2006 Pages: 689 - 698
Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer Francesco RecchiaGaetano SaggioSilvio Rea Original Article 06 September 2006 Pages: 699 - 708
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination Teresa CabreraEster LaraFederico Garrido Original Article 08 September 2006 Pages: 709 - 717
HLA-A0201 positive pancreatic cell lines: new findings and discrepancies Kuichun ZhuGregory LizeeDavid Z. Chang Short Communication 01 September 2006 Pages: 719 - 724
Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund–Wistar rats Julie E. HeinrichMorris PollardMark A. Suckow Short Communication 05 September 2006 Pages: 725 - 730
Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy Andreas HombachHinrich Abken Symposium Paper 02 December 2006 Pages: 731 - 737
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion Christian BlankAndreas Mackensen Symposium Paper 29 December 2006 Pages: 739 - 745